| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Priority Reports |
Departments of 1 Physiological Chemistry and 2 Pathology, University Medical Center Utrecht, Utrecht, the Netherlands; 3 Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands
Requests for reprints: Frank C.P. Holstege, Department of Physiological Chemistry, University of Medical Center Utrecht, Universiteitsweg 100, 3584 CG Utrecht, the Netherlands. Phone: 31-30-2538186; Fax: 31-30-2539035; E-mail: f.c.p.holstege{at}med.uu.nl.
Spread of cancer and development of solid metastases at distant sites is the main cause of cancer-related deaths. To understand and treat metastases, it is important to determine at which stages the most pivotal steps for development of metastases occur. In head and neck squamous cell carcinoma (HNSCC), metastasis nearly always occurs first in local lymph nodes before development of distant metastasis. Here, we have investigated gene expression patterns in HNSCC lymph node metastases using DNA microarrays. Several types of analyses show that the gene expression patterns in lymph node metastases are most similar to the corresponding primary tumors from which they arose, as long as samples contain sufficient proportions of tumor cells. Strikingly, gene expression patterns of metastatic primary HNSCC are largely maintained upon spread to the lymph node. Only a single gene, metastasis-associated gene 1 (MTA1), was found to show consistently changed expression between a large number of matched primary tumor-lymph node metastasis pairs. The maintained expression pattern includes the predictive signature for HNSCC lymph node metastasis. These results underscore the importance of the primary tumor gene expression profile for development and treatment of metastasis. The findings also agree with the concept that disseminated cancer cells alter the surrounding tissue into a metastatic environment that resembles the primary tumor microenvironment. (Cancer Res 2006; 66(23): 11110-4)
This article has been cited by other articles:
![]() |
S. M. Lagarde, P. E. Ver Loren van Themaat, P. D. Moerland, L. A. Gilhuijs-Pederson, F. J. W. ten Kate, P. H. Reitsma, A. H. C. van Kampen, A. H. Zwinderman, F. Baas, and J. J. B. van Lanschot Analysis of Gene Expression Identifies Differentially Expressed Genes and Pathways Associated with Lymphatic Dissemination in Patients with Adenocarcinoma of the Esophagus Ann. Surg. Oncol., December 1, 2008; 15(12): 3459 - 3470. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Bennett, B. Hackanson, L. T. Smith, C. D. Morrison, J. C. Lang, D. E. Schuller, F. Weber, C. Eng, and C. Plass Tumor Suppressor Activity of CCAAT/Enhancer Binding Protein {alpha} Is Epigenetically Down-regulated in Head and Neck Squamous Cell Carcinoma Cancer Res., May 15, 2007; 67(10): 4657 - 4664. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |